SKF96365 |
|
TRPC1, TRPC2, TRPC3, TRPC4, TRPC5, TRPC6, TRPC7 |
Selectively decrease receptor-mediated calcium entry (RMCE) in human platelets, neutrophils and endothelial cells |
Inhibit receptor-mediated Ca2+ entry and voltage-gated Ca2+ entry |
Merritt et al., 1990; Farooqi et al., 2013
|
Pyrazole-3 (Pyr3) |
|
TRPC3 |
Prevent stent-induced arterial remodeling and inhibit SMC proliferation |
Inhibit TRPC3 by binding to the extracellular side of the receptor |
Rowell et al., 2010; Christian and Maik, 2011; Koenig et al., 2013
|
SAR7334 |
|
TRPC3, TRPC6, TRPC7 |
Effect on acute hypoxic pulmonary vasoconstriction and systemic blood pressure |
Inhibit TRPC3, TRPC6, TRPC7-mediated Ca2+ influx into cells |
Maier et al., 2015 |
GsMTx-4 |
Gly-Cys-Leu-Glu-Phe-Trp-Trp-Lys-Cys-Asn-Pro-Asn-Asp-Asp-Lys-Cys-Cys-Arg-Pro-Lys-Leu-Lys-Cys-Ser-Lys-Leu-Phe-Lys-Leu-Cys-Asn-Phe-Ser-Phe-NH2 |
Stretch-activated ion channels and NaV1.7 Na + channels and TRPC1, TRPC6 |
Potential therapeutic targets for cardiac arrhythmias |
Inhibit Na+ voltage-gated channels and cation-selective mechanosensitive channels |
Franz and Bode, 2003; Bowman et al.,2007; Rowell et al., 2010
|
BTP2 |
|
TRPCs and Store-operated Ca2+ influx and Ca2+ release-activat ed Ca2+ channels |
Suppresses cytokine production (IL-2, IL-4, IL-5, IFN-γ, etc.) and proliferation in T cells in vitro
|
Inhibit anti-CD3 antibody-induced sustained Ca2+ influx |
Ohga et al., 2008; Rowell et al., 2010
|